PSNL.NASDAQPersonalis, INC

Form 4: Personalis CEO Executes Stock Option Plan

Sentiment:

Statement of Changes in Beneficial Ownership


CEO Christopher M. Hall exercised options and sold 100,000 shares of Personalis, Inc. common stock under a pre-arranged 10b5-1 trading plan.

Summary

  • CEO Christopher M. Hall exercised options for 100,000 shares of common stock at an exercise price of $1.61 per share.
  • The shares were acquired in two tranches: 19,909 shares on May 28, 2026, and 80,091 shares on May 29, 2026.
  • All acquired shares were subsequently sold at a weighted average price of $11.02 per share.
  • The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on December 17, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted through a pre-arranged 10b5-1 plan, which is a routine mechanism for executive compensation liquidity.

Positives

  • The transaction was executed under a pre-established Rule 10b5-1 plan, indicating a systematic approach to equity management rather than reactive selling.
  • The CEO maintains a significant remaining beneficial ownership of 235,986 shares.

Negatives

  • The transaction represents a divestment of 100,000 shares by the Chief Executive Officer.

Risks

  • Future share price volatility could impact the value of the CEO's remaining holdings.
  • Reliance on Rule 10b5-1 plans does not eliminate the potential for negative market perception regarding insider selling.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Management Comments

  • The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 17, 2025.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to diversify personal holdings and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

  • The use of Rule 10b5-1 plans is the industry standard for executives to avoid allegations of insider trading while liquidating equity compensation.

Stakeholder Impact

  • Shareholders should note the reduction in the CEO's direct equity stake, though the use of a 10b5-1 plan mitigates concerns regarding insider sentiment.

Next Steps

  • Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

DateDescription
2025-12-17Adoption date of the Rule 10b5-1 trading plan.
2026-05-28First tranche of option exercise and sale.
2026-05-29Second tranche of option exercise and sale.

Keywords

Personalis, PSNL, Insider Trading, Form 4, Christopher Hall, Stock Options, 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.